RecruitingNot ApplicableNCT07225660

Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)

A Randomized Blinded Controlled Trial Assessing Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)


Sponsor

Shady Grove Fertility Reproductive Science Center

Enrollment

394 participants

Start Date

Feb 25, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

HOLIDAY is a two-arm, parallel-group, multi-center, randomized trial in which subjects undergoing planned oocyte cryopreservation will be randomized to receive either a 2-month pause of Combined Hormonal Contraceptives (CHC) or immediate start (without a pause).


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Inclusion Criteria3

  • Ovary-bearing individuals 18 to 40 years of age.
  • BMI < 40 kg/m2
  • Non-smoker for at least 3 months prior to study enrollment.

Exclusion Criteria3

  • BMI greater than or equal to 40 kg/m2
  • Current Smoker
  • Any contraindications to ovarian stimulation or outpatient egg retrieval under anesthesia

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROCP pause

Subjects in the study arm will be asked to discontinue combined hormonal contraceptives (CHC) for 2 months prior to planned oocyte cryopreservation


Locations(3)

Yale Fertility Center

Orange, Connecticut, United States

Shady Grove Fertility Rockville

Rockville, Maryland, United States

Reproductive Medicine Associates of New York

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07225660


Related Trials